{
  "cik": "0001885827",
  "name": "Virax Biolabs Group Ltd",
  "entityType": "other",
  "sic": "2835",
  "sicDescription": "In Vitro & In Vivo Diagnostic Substances",
  "stateOfIncorporation": "E9",
  "stateOfIncorporationDescription": "Cayman Islands",
  "fiscalYearEnd": "0331",
  "tickers": [
    "VRAX"
  ],
  "exchanges": [
    "Nasdaq"
  ],
  "ein": "000000000",
  "description": "",
  "website": "",
  "investorWebsite": "",
  "category": "Non-accelerated filer<br>Emerging growth company",
  "phone": "44 020 7788 7414",
  "flags": "",
  "formerNames": [
    {
      "name": "Virax Biolabs (Cayman) Ltd",
      "from": "2021-12-27T05:00:00.000Z",
      "to": "2021-12-27T05:00:00.000Z"
    }
  ],
  "filings_count": 116,
  "download_timestamp": "2025-08-02 07:28:44 UTC"
}